Related Experiment Video
Updated: Mar 26, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
Mark R Woodford1, Andrew W Truman2, Diana M Dunn1
1Department of Urology, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA; Cancer Research Institute, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA.
Abstract:
The molecular chaperone Hsp90 protects deregulated signaling proteins that are vital for tumor growth and survival. Tumors generally display sensitivity and selectivity toward Hsp90 inhibitors; however, the molecular mechanism underlying this phenotype remains undefined. We report that the mitotic checkpoint kinase Mps1 phosphorylates a conserved threonine residue in the amino-domain of Hsp90. This, in turn, regulates chaperone function by reducing Hsp90 ATPase activity while fostering Hsp90 association with kinase clients, including Mps1. Phosphorylation of Hsp90 is also essential for the mitotic checkpoint because it confers Mps1 stability and activity. We identified Cdc14 as the phosphatase that dephosphorylates Hsp90 and disrupts its interaction with Mps1. This causes Mps1 degradation, thus providing a mechanism for its inactivation. Finally, Hsp90 phosphorylation sensitizes cells to its inhibitors, and elevated Mps1 levels confer renal cell carcinoma selectivity to Hsp90 drugs. Mps1 expression level can potentially serve as a predictive indicator of tumor response to Hsp90 inhibitors.
Insights
The mitotic checkpoint kinase Mps1 regulates Hsp90 chaperone activity through phosphorylation, impacting tumor cell survival and sensitivity to Hsp90 inhibitors. Mps1 levels may predict patient response to these cancer drugs.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- The molecular chaperone Hsp90 is crucial for tumor growth and survival by stabilizing deregulated signaling proteins.
- Tumors exhibit sensitivity and selectivity towards Hsp90 inhibitors, but the underlying molecular mechanisms are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanism by which Hsp90 function is regulated in cancer.
- To investigate the role of Mps1 in Hsp90 regulation and its implications for Hsp90 inhibitor efficacy.
Main Methods:
- Investigated the phosphorylation of Hsp90 by Mps1 using biochemical assays.
- Analyzed the effect of Hsp90 phosphorylation on its ATPase activity and client interactions.
- Identified the phosphatase responsible for Hsp90 dephosphorylation and its impact on Mps1 stability.
- Correlated Mps1 expression levels with tumor response to Hsp90 inhibitors in renal cell carcinoma models.
Main Results:
- Mps1 phosphorylates Hsp90 at a conserved threonine residue, reducing its ATPase activity and promoting association with kinase clients like Mps1.
- Hsp90 phosphorylation is essential for mitotic checkpoint function by stabilizing Mps1.
- Cdc14 phosphatase dephosphorylates Hsp90, leading to Mps1 degradation and inactivation.
- Hsp90 phosphorylation sensitizes cells to Hsp90 inhibitors, and elevated Mps1 levels confer selectivity to Hsp90 drugs in renal cell carcinoma.
Conclusions:
- Mps1-mediated phosphorylation of Hsp90 is a key regulatory mechanism controlling chaperone activity and mitotic checkpoint function.
- This regulatory axis provides a molecular basis for tumor sensitivity and selectivity to Hsp90 inhibitors.
- Mps1 expression levels can serve as a predictive biomarker for patient response to Hsp90-targeted cancer therapies.
More Related Videos
06:51Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Abnormal Proliferation
MAPK Signaling Cascades